Aurinia Pharmaceuticals Inc.
Save
–
Market cap
–
Current P/E
–
Forward P/E
About
Health care
Sector
Medical - Specialties
Industry
Aurinia Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops and commercializes therapies to treat various diseases in the United States and China. It is involved in developing voclosporin, an investigational drug for the treatment of lupus nephritis, dry eye syndrome, and focal segmental glomerulosclerosis. The company is headquartered in Victoria, Canada.
Similar securities
Based on sector and market capitalization
Report issue